Contact this trialFirst, we need to learn more about you.
Cancer Vaccine
DPX-Survivac + Pembrolizumab for Lymphoma
Recruiting1 awardPhase 2
Saskatoon, Saskatchewan
This trial is testing a new cancer treatment combining two drugs, one of which is a new experimental drug. They are testing to see if it is safe and effective in people with a certain type of lymphoma that has come back or didn't respond to other treatments.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service